Available in 2017, 2018

Course handbook


This course uses the cognitive and technical skills in molecular medicine and pharmacogenomincs learnt over the program to discuss advanced molecular basis of altered health states and drug response. As knowledge of the genetic basis of disease increases so does the opportunities for drug targeting and patient specific-treatments. This course considers the two key elements of the genetics of disease and the genetics of drug response (pharmacogenomics) and their inter-relationship.

Availability2017 Course Timetables


  • Semester 2 - 2017
  • Semester 2 - 2018

Learning outcomes

On successful completion of the course students will be able to:

1. Have an advanced understanding of the molecular basis of disease;

2. Demonstrate an understanding of the molecular determinants of drug response;

3. Discuss the molecular basis of cancer therapeutics;

4. Discuss the impact of biotherapy on therapeutics, pharmaceutical industry and society; and

5. Develop an understanding of the advanced ethical issues related to the use of biotherapy.


  1. Drug targets
  2. Genomics
  3. Proteomics
  4. Pharmacogenetics
  5. Pharmacogenomics
  6. Monoclonal antibody therapeutics
  7. Peptide-based therapeutics
  8. Nucleic Acid therapeutics including anti-sense and gene-therapy
  9. Cell-based therapeutics
  10. SNP analysis
  11. Ethical issues arising from the use of biotherapeutics


PHAR4201 Pre-Requisites and requirements for Bachelor of Pharmacy (Honours) 12328 program.

Assumed knowledge

HUBS1202 Human Genomics and Biomolecular Analysis.

Assessment items

Formal Examination: Written Exam

Quiz: Online Quizzes

Contact hours



Face to Face On Campus 2 hour(s) per Week for 8 Weeks


Face to Face On Campus 2 hour(s) per Week for 8 Weeks